| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Gueutin V et al. | [Diabetic nephropathy: emerging treatments]. | 2014 | Nephrol. Ther. | pmid:24938412 |
| Abdul Gafor AH et al. | Intravenous calcitriol versus paricalcitol in haemodialysis patients with severe secondary hyperparathyroidism. | 2009 | Nephrology (Carlton) | pmid:19298641 |
| Ong LM et al. | Randomized controlled trial to compare the efficacy and safety of oral paricalcitol with oral calcitriol in dialysis patients with secondary hyperparathyroidism. | 2013 | Nephrology (Carlton) | pmid:23311404 |
| Carr RA et al. | The effect of hepatic insufficiency on the safety and pharmacokinetics of paricalcitol (Zemplar). | 2006 | Nephron Clin Pract | pmid:16534233 |
| Schumock GT et al. | Comparative effectiveness of paricalcitol versus cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. | 2011 | Nephron Clin Pract | pmid:20699620 |
| Verouti SN et al. | Vitamin D receptor activators upregulate and rescue podocalyxin expression in high glucose-treated human podocytes. | 2012 | Nephron Exp. Nephrol. | pmid:23548800 |
| Karavalakis E et al. | Paricalcitol treatment and arterial tone in experimental renal insufficiency. | 2008 | Nephron Exp. Nephrol. | pmid:18663335 |
| Schroeder NJ et al. | Effects of 'non-calcaemic' vitamin D analogues on 24-hydroxylase expression in MG-63 osteoblast-like cells. | 2003 | Nephron Physiol | pmid:12972708 |
| Fryer RM et al. | Differential inhibition of renin mRNA expression by paricalcitol and calcitriol in C57/BL6 mice. | 2007 | Nephron Physiol | pmid:17622742 |
| Cozzolino M et al. | Vitamin D receptor activation and prevention of arterial ageing. | 2012 | Nutr Metab Cardiovasc Dis | pmid:22633189 |
Paricalcitol
Paricalcitol is a lipid of Sterol Lipids (ST) class. Paricalcitol is associated with abnormalities such as Vitamin D Deficiency. The involved functions are known as Hypertrophy, Left Ventricular. Paricalcitol often locates in Blood.
Cross Reference
Introduction
To understand associated biological information of Paricalcitol, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Paricalcitol?
Paricalcitol is suspected in Vitamin D Deficiency and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
No disease MeSH terms mapped to the current reference collection.
PubChem Associated disorders and diseases
What pathways are associated with Paricalcitol
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Paricalcitol?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Paricalcitol?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Paricalcitol?
There are no associated biomedical information in the current reference collection.
What genes are associated with Paricalcitol?
There are no associated biomedical information in the current reference collection.
What common seen animal models are associated with Paricalcitol?
There are no associated biomedical information in the current reference collection.